AHCL vs DRAGARWQ: Stock Comparison

Anlon Healthcare Limited vs Dr Agarwals Eye Hospital Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Dr Agarwals Eye Hospital Ltd is the larger company by market capitalisation. Anlon Healthcare Limited shows a lower P/E, faster revenue growth and lower leverage, while Dr Agarwals Eye Hospital Ltd shows a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Anlon Healthcare Limited and Dr Agarwals Eye Hospital Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AHCL is more favourable on 6 of 13 scored metrics and DRAGARWQ on 7These counts are context-free and are not an overall rating.

Key Differences

Market Cap
DRAGARWQ is the larger company
₹2,412 Cr vs ₹797 Cr
P/E Ratio
AHCL has a lower P/E
27.78x vs 34.61x
P/B Ratio
AHCL has a lower P/B
3.46x vs 7.01x
EPS
DRAGARWQ has higher earnings per share
₹145 vs ₹0.61
Dividend Yield
DRAGARWQ has a higher dividend yield
0.13% vs 0%
Revenue Growth (TTM YoY)
AHCL has faster revenue growth
4% vs 0%
EPS Growth (TTM YoY)
DRAGARWQ has faster EPS growth
0% vs -54.8%
Qtr Sales Growth
DRAGARWQ has stronger quarterly sales growth
20.2% vs 4.01%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAHCLDRAGARWQ
SectorHealthcare
IndustryPharmaceuticals

Price

MetricAHCLDRAGARWQ
Live Price₹15.01₹5,021.5
Day Change-0.46%0.1%
Volume28.27 L164
52-Week High₹161₹6,059.7
52-Week Low₹12.91₹4,600
Distance from 52W High-90.68%-17.13%

Valuation

MetricAHCLDRAGARWQ
Market Cap₹797 Cr₹2,412 Cr
P/E Ratio27.78x34.61x
P/B Ratio3.46x7.01x
EPS₹0.61₹145
Book Value₹5.11₹717
Dividend Yield0%0.13%

Growth

MetricAHCLDRAGARWQ
Revenue Growth (TTM YoY)4%0%
EPS Growth (TTM YoY)-54.8%0%
Qtr Sales Growth4.01%20.2%
Qtr Profit Growth-36.9%1.56%

Profitability & Leverage

MetricAHCLDRAGARWQ
ROE18.4%25.2%
ROCE20.8%17.4%
Net Margin22.18%14.89%
Operating Margin27.6%30.9%
Debt to Equity0.19x0.94x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricAHCLDRAGARWQ
Promoter Holding52.68%72.67%
FII Holding0.32% 0.09 pp2.2% 0.38 pp
DII Holding4.6% 0.11 pp2.12% 0.24 pp
Public Holding42.4% 0.2 pp23% 0.15 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Anlon Healthcare Limited and Dr Agarwals Eye Hospital Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.